Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

Autor: Raffi, François, Babiker, Abdel G, Richert, Laura, Molina, Jean-Michel, George, Elizabeth C, Antinori, Andrea, Arribas, Jose R, Grarup, Jesper, Hudson, Fleur, Schwimmer, Christine, Saillard, Juliette, Wallet, Cédrick, Jansson, Per O, Allavena, Clotilde, Van Leeuwen, Remko, Delfraissy, Jean-François, Vella, Stefano, Chêne, Geneviève, Pozniak, Anton
Zdroj: In The Lancet 29 November-5 December 2014 384(9958):1942-1951
Databáze: ScienceDirect